Advanced search
Publication Cover
Infectious Diseases Volume 54, 2022 - Issue 10
Submit an article Journal homepage
1,351
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Clinical and genomic characterisation of a fatal Puumala orthohantavirus case with low levels of neutralising antibodies

Anne Tuiskunen Bäcka Infection and Immunology, Department of Clinical Microbiology, Umeå University, Umeå, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9821-1348View further author information
ORCID Icon,
Johan Rasmusona Infection and Immunology, Department of Clinical Microbiology, Umeå University, Umeå, SwedenView further author information
,
Therese Thunberga Infection and Immunology, Department of Clinical Microbiology, Umeå University, Umeå, SwedenView further author information
,
Gregory Rankinb Medicine and Pulmonary Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, SwedenView further author information
,
Julia Wigren Byströma Infection and Immunology, Department of Clinical Microbiology, Umeå University, Umeå, SwedenView further author information
,
Charlotta Anderssonc Pathology, Department of Medical Biosciences, Umeå University, Umeå, SwedenView further author information
,
Andreas Sjödind CBRN Security and Defence, Swedish Defence Research Agency - FOI, Umeå, SwedenView further author information
,
Mattias Forsella Infection and Immunology, Department of Clinical Microbiology, Umeå University, Umeå, SwedenView further author information
&
Clas Ahlma Infection and Immunology, Department of Clinical Microbiology, Umeå University, Umeå, SwedenView further author information
 show all
Pages 766-772 | Received 17 Feb 2022, Accepted 07 May 2022, Published online: 17 Jun 2022

References

  • Vapalahti O, Mustonen J, Lundkvist A, et al. Hantavirus infections in Europe. Lancet Infect Dis. 2003;3(10):653–661.
  • Laenen L, Vergote V, Calisher CH, et al. Hantaviridae: current classification and future perspectives. Viruses. 2019;11(9):788.
  • Hjertqvist M, Klein SL, Ahlm C, et al. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis. 2010;16(10):1584–1586.
  • Pettersson L, Boman J, Juto P, et al. Outbreak of Puumala virus infection, Sweden. Emerg Infect Dis. 2008;14(5):808–810.
  • Johansson P, Olsson M, Lindgren L, et al. Complete gene sequence of a human Puumala hantavirus isolate, Puumala Umeå/hu: sequence comparison and characterisation of encoded gene products. Virus Res. 2004;105(2):147–155.
  • Vial PA, Valdivieso F, Calvo M, et al. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus. Antivir Ther. 2015;20(4):377–386.
  • Pettersson L, Thunberg T, Rocklov J, et al. Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients–implications for treatment. Clin Microbiol Infect. 2014;20(3):235–241.
  • Valdivieso F, Vial P, Ferres M, et al. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerg Infect Dis. 2006;12(1):166–168.
  • Charignon D, Spath P, Martin L, et al. Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems. Expert Opin Pharmacother. 2012;13(15):2233–2247.
  • Antonen J, Leppanen I, Tenhunen J, et al. A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Scand J Infect Dis. 2013;45(6):494–496.
  • Vaheri A, Strandin T, Jaaskelainen AJ, et al. Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Antiviral Res. 2014;111:23–25.
  • Laine O, Leppanen I, Koskela S, et al. Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant. Infect Dis (Lond). 2015;47(2):107–111.
  • Bergstedt Oscarsson K, Brorstad A, Baudin M, et al. Human Puumala hantavirus infection in Northern Sweden; increased seroprevalence and association to risk and health factors. BMC Infect Dis. 2016;16(1):566.
  • Vapalahti K, Virtala AM, Vaheri A, et al. Case-control study on Puumala virus infection: smoking is a risk factor. Epidemiol Infect. 2010;138(4):576–584.
  • Gherasim A, Hjertqvist M, Lundkvist A, et al. Risk factors and potential preventive measures for nephropatia epidemica in Sweden 2011–2012: a case-control study. Infect Ecol Epidemiol. 2015;5:27698.
  • Bharadwaj M, Nofchissey R, Goade D, et al. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis. 2000;182(1):43–48.
  • Yi J, Xu Z, Zhuang R, et al. Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity. J Infect Dis. 2013;207(9):1457–1461.
  • Mittler E, Wec AZ, Tynell J, et al. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses. Sci Transl Med. 2022;14(636):eabl5399.
  • Plyusnina A, Razzauti M, Sironen T, et al. Analysis of complete Puumala virus genome, Finland. Emerg Infect Dis. 2012;18(12):2070–2072.
  • Pal E, Korva M, Resman Rus K, et al. Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome. PLoS One. 2018;13(5):e0197661.
  • Mir MA. Hantaviruses. Clin Lab Med. 2010;30(1):67–91.
  • Lundkvist A, Kallio-Kokko H, Sjolander KB, et al. Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. Virology. 1996;216(2):397–406.
  • Matthys V, Mackow ER. Hantavirus regulation of type I interferon responses. Adv Virol. 2012;2012:524024.
  • Reip A, Haring B, Sibold C, et al. Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype. Arch Virol. 1995;140(11):2011–2026.
  • Serris A, Stass R, Bignon EA, et al. The hantavirus surface glycoprotein lattice and its fusion control mechanism. Cell. 2020;183(2):442–456 e16.
  • Muyangwa M, Martynova EV, Khaiboullina SF, et al. Hantaviral proteins: structure, functions, and role in hantavirus infection. Front Microbiol. 2015;6:1326.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.